Education
School ¡X Major ¡X Degree | Duration |
---|---|
°ê¥ß¶§©ú¤j¾Ç ¡X ¥Íª«Âå¾Ç¼v¹³º[©ñ®g¬ì¾Ç¨t(²¦) ¡X ³Õ¤h PhD, Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University |
2002/09 ¡X 2008/01 |
°ê¥ß¶§©ú¤j¾Ç ¡X Âå¾Ç©ñ®g§Þ³N¾Ç¨t(²¦) ¡X ¾Ç¤h Bachelor, Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University |
1996/09 ¡X 2000/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
Âå¾Ç¼v¹³º[©ñ®g¬ì¾Ç¨t Department of Medical Imaging and Radiological Sciences | Associate Professor | 2016/08/01 ¡X |
Âå¾Ç¼v¹³º[©ñ®g¬ì¾Ç¨t Department of Medical Imaging and Radiological Sciences | Assistant Professor | 2009/08/01 ¡X 2016/07/31 |
Extramural Experience
DEPNO | Position- Office/Department/Institute | Duration |
---|---|---|
¤¤»O¬ì§Þ¤j¾Ç | §U²z±Ð±Â | 0961105 ¡X 0970731 |
Discipline
NO | Discipline | Expertise |
---|---|---|
1 | ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture | ©ñ®g½u¬ì¤Î®Ö¤lÂå¾Ç¬ì Division of Radiology and Nuclear Medicine |
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
¤À¤l¤Î°ò¦]¼v¹³§Þ³N¤ÎÀ³¥Î¬ã¨s¡B°ò¦]ÅéÂå¾Ç¤ÎÃĪ«¤§¬ã¨s
Molecular imaging and pharmacogenomics studies
Area(s) of Expertise & Research
¤À¤l¼v¹³¡F¿ç®g¥Íª«¾Ç ; ©ñ®g¸~½F¥Íª«¾Ç
molecular imaging, radiobiology, radiation oncology
Publication
NO | Publication |
---|---|
1 | Preclinical Characterization and In Vivo Imaging of 111In-Labeled Mesenchymal Stem Cell¡VDerived Extracellular Vesicles Preclinical Characterization and In Vivo Imaging of 111In-Labeled Mesenchymal Stem Cell¡VDerived Extracellular Vesicles |
2 | Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant . Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant . |
3 | In Vitro and In Vivo Evaluations of £]-Lactam/£]-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan. In Vitro and In Vivo Evaluations of £]-Lactam/£]-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan. |
4 | «æºC©Ê°sºë¤¤¬r¹ï¤j¹«¸£³¡¥NÁ¤A»Ä¯à¤Oªº¼vÅT Effects of the acute and chronic ethanol intoxication on acetate metabolism and kinetics in the rat brain |
5 | 18F-FDGÄá¨ú»P¥Òª¬¸¢Àù·F²ÓM¤§Ãö«Y Correlation of 18F-FDG uptake and thyroid cancer stem cells |
6 | Fli-1¹L«×ªí²{©M¬Pª¬²ÓM½Fªº¹w«á®t¦³Ãö³s©Ê Overexpression of Fli-1 in astrocytoma is associated with poor prognosis |
7 | °w¹ï»ó«|Àù©ñ®gªvÀø«á®ü°¨°j¾D¨ü·L¾¯¶qÃnÅS«áªº»{ª¾¥\¯àµû¦ô Prognosis of Hippocampal Function after Sub-lethal Irradiation Brain Injury in Patients with Nasopharyngeal Carcinoma. |
8 | §Q¥ÎµL¼Ò¦¡¤Æ®ÉªÅ¶¡¸s»Eªk¨Ó¦ôpfMRI¯«¸g¤ÏÀ³¬¡«× Adapted estimate of neural activity based on blood-oxygen-level dependent signal by a model-free spatio-temporal clustering analysis |
9 | §Q¥ÎÃþ¯«¸g¤Î¤ä«ù¦V¶q¨t²Î¨Ó¶i¦æEEG¾îÂ_±ÀR§¤¸gÅç¤ÀªR A cross-sectional evaluation of meditation experience on electroencephalography data by artificial neural network and support vector machine classifiers |
10 | Quantitative Measurement of the Thyroid Uptake Function of Mouse by Cerenkov Luminescence Imaging Quantitative Measurement of the Thyroid Uptake Function of Mouse by Cerenkov Luminescence Imaging |
11 | ·s«¬¬ï³z¦¡X¥ú»ö¾¹ªºª«²z¤Î¥Íª«Âå¾Ç¯S©Ê The physical and biomedical characteristics of the novel transmission type X-ray equipment |
12 | Ovatodiolide of Anisomeles indica, exerts the anti-cancer potential on pancreatic cancer cell lines through STAT3 and NF-£eB regulation Ovatodiolide of Anisomeles indica, exerts the anti-cancer potential on pancreatic cancer cell lines through STAT3 and NF-£eB regulation |
13 | Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum £]-lactamase-producing Klebsiella pneumoniae isolates. Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum £]-lactamase-producing Klebsiella pneumoniae isolates. |
14 | Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis |
15 | ¥HCArG«½Æ§Ç¦C§@¬°©ñ®g½u»¤¾É¤§¤À¤l¼v¹³¶}Ãö Demonstration of tightly radiation-controlled molecular switch based on CArG repeats by in vivo molecular imaging |
16 | ¥Ñ¦åºÞ¤º¥Ö²ÓM¤Àªc¤§¦åºÞ¦¬ÁY¯À쬰¦åºÞ««Øªº«n½Õ¸`ªÌ Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling |
17 | P21-driven multi-fusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor P21-driven multi-fusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor |
18 | Rational Design of a Triple Reporter Gene for Multimodality Molecular Imaging Rational Design of a Triple Reporter Gene for Multimodality Molecular Imaging |
19 | Binding of HIV-1 gp120 to DC-SIGN Promotes ASK-1-Dependent Activation-Induced Apoptosis of Human Dendritic Cells. Binding of HIV-1 gp120 to DC-SIGN Promotes ASK-1-Dependent Activation-Induced Apoptosis of Human Dendritic Cells. |
20 | Molecular Imaging of Nonsmall Cell Lung Carcinomas Expressing Active Mutant EGFR Kinase Using PET with [124I]-Morpholino-IPQA Molecular Imaging of Nonsmall Cell Lung Carcinomas Expressing Active Mutant EGFR Kinase Using PET with [124I]-Morpholino-IPQA |
21 | The EIIAPA Chimeric Promoter for Tumor Specific Gene Therapy of Hepatoma The EIIAPA Chimeric Promoter for Tumor Specific Gene Therapy of Hepatoma |
22 | A Study on the Dose Distributions in Various Materials from an Ir-192 HDR Brachytherapy Source A Study on the Dose Distributions in Various Materials from an Ir-192 HDR Brachytherapy Source |
23 | Specific Activation of Sodium/iodide Symporter Gene in Hepatoma Using Alpha-fetoprotein Promoter Combined with Hepatitis B Virus Enhancer (EIIAPA) Specific Activation of Sodium/iodide Symporter Gene in Hepatoma Using Alpha-fetoprotein Promoter Combined with Hepatitis B Virus Enhancer (EIIAPA) |
Project
NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
---|---|---|
1 |
109 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST109-2314-B-037-032 ¡X 1 Ó¤H«¬
µo®i¨Ã±´°Q¸g¤fµÄÂH½¤¹B°e¤§´ß»E¿}©`¦Ì¸üÅé¸Ë¸ümiR-30c-5p¦b¤fµÄÀùªº§ÜÀù¤Î¿ç®g¼W±Ó®ÄªG( )
|
2020/08/01 ~ 2021/07/31 |
2 |
108 ¡X A ì©e·| ¡X NL1090583 ¡X
109¦~«×gamma-H2AX¤ÀªR¬ã¨s¤Î¬V¦âÅéÂù¤¤¸`¤ÀªR³Ò°È®×( )
|
2020/06/23 ~ 2020/10/31 |
3 |
108 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST108-2314-B-037-023 ¡X 1 Ó¤H«¬
GSKIPÂǥѽձ±²É½uÅé°ÊºA»P¸~½F·F²ÓM¥H«P¶i¤fµÄÀù¿ç®g§Ü©Ê¤§¨¤¦â±´°Q( )
|
2019/08/01 ~ 2020/10/31 |
4 |
107 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST107-2314-B-037-049 ¡X 1 Ó¤H«¬
±´°QFli-1©ó¤fµÄÅ쪬¤W¥Ö²ÓMÀù¿ç®g§Ü©Ê¤§¨¤¦â¥H¤Î³J¥Õ½è¤AñQ¤Æ§@¥Î¹ïFli-1©Ò½Õ¸`¤§¿ç®g§Ü©Ê¼vÅT( )
|
2018/08/01 ~ 2019/07/31 |
5 |
106 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST106-2314-B-037-020 ¡X 1 Ó¤H«¬
±´°Q¦b¤fµÄÅ쪬¤W¥Ö²ÓMÀù¤ºGSKIP©MWntless¹ïWnt/beta-catenin¸ô®|©Ò½Õ±±¤§©ñ®g±Ó·P«×ªº¼vÅT:Á{§É¯f²zµ²ªG¤§¼ç¤O¹w´ú¦]¤l( )
|
2017/08/01 ~ 2018/07/31 |
6 |
105 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST104-2314-B-037-055-MY2 ¡X 1 Ó¤H«¬
¶}µo¨ã³J¥Õ酶¨Ì¿à©Ê³y¼v±´°w¥H°»´ú©M°lÂܤ饻¸£ª¢¯f¬r(JEV)¦b¬¡Åé¤À§G±¡§Î(2/2)( )
|
2016/08/01 ~ 2017/07/31 |
7 |
105 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP105PR11 ¡X
±´°Q¤fµÄÀù²ÓM·Ó®g«á¤§¦Û¾½§@¥Î¨¤¦â( )
|
2017/02/01 ~ 2017/10/31 |
8 |
104 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST104-2314-B-037-055-MY2 ¡X 1 Ó¤H«¬
¶}µo¨ã³J¥Õ酶¨Ì¿à©Ê³y¼v±´°w¥H°»´ú©M°lÂܤ饻¸£ª¢¯f¬r(JEV)¦b¬¡Åé¤À§G±¡§Î(1/2)( )
|
2015/08/01 ~ 2017/07/31 |
9 |
104 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP104PR29 ¡X
¥H°Êª«¼Ò¦¡ÅçÃÒ³J¥Õ酶¨Ì¿à©Ê³y¼v±´°w¥H°»´ú©M°lÂܤ饻¸£ª¢¯f¬r(JEV)¦b¬¡Åé¤À§G±¡§Î( )
|
2016/05/01 ~ 2016/09/30 |
10 |
104 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST105-2815-C-037-030-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
105¦~«×¤j±M¾Ç¥Í¬ã¨spµe-¼B§ü¬À(¥Íª«2)( )
|
2016/07/01 ~ 2017/02/28 |
11 |
103 ¡X N ¬ì§Þ³¡(ì°ê¬ì·|) ¡X MOST103-2314-B-037-007 ¡X 1 Ó¤H«¬
¶}µo¨ã³J¥Õ酶¨Ì¿à©Ê³y¼v±´°w¥H°»´ú©M°lÂܶÀ¯f¬r(HCV/JEV)¦b¬¡Åé¤À§G±¡§Î( )
|
2014/08/01 ~ 2015/07/31 |
12 |
102 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X 103-2815-C-037-027-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
103¦~«×¤j±M¾Ç¥Í¬ã¨spµe-±iÃLø@(Âå©ñ2)( )
|
2014/07/01 ~ 2015/02/28 |
13 |
099 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X Q100018 ¡X
¬¡Å餺¸~½F·F²ÓM¤§¥ÜÂÜ»P¤ÀÂ÷( )
|
2011/01/01 ~ 2011/12/31 |
14 |
098 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q099026 ¡X
¥H¾½µßÅéªí¹F§Þ³N¿z¿ï¥X¹ï¤£¦Psomatostatin±µ¨ü¾¹¨ã¿ï¾Ü©Êµ²¦Xªº³æÃì§ÜÅé( )
|
2010/02/01 ~ 2010/12/31 |